课题基金 / 基金详情

Predictive biomarkers for adjuvant immune checkpoint inhibitor therapy in non-small cell lung cancer

Predictive biomarkers for adjuvant immune checkpoint inhibitor therapy in non-small cell lung cancer
非小细胞肺癌辅助免疫检查点抑制剂治疗的预测生物标志物
批准号:
469156
负责人:
Tsao Ming-Sound
金额:
$89.17万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
未结题
起止时间:
2022-09-01 至 2027-09-01

项目摘要

项目成果

Tsao Ming-Sound的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Lung cancer is the leading cause of cancer death worldwide, with only 16% of patients alive at 5 years. Non-small cell lung cancer (NSCLC) makes up at least 80% lung cancers. For patients diagnosed with late-stage NSCLC without driver mutations that can b
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multimodal strategy to identify novel diagnostic and therapeutic targets in lung and pancreatic cancer
  • 批准号:
    333769
  • 项目类别:
    Operating Grants
  • 资助金额:
    $272.35万
  • 财政年份:
    2015
  • 负责人:
    Tsao Ming-Sound
  • 依托单位:
Development of a monoclonal antibody for integrin alpha-11 to treat lung cancer
  • 批准号:
    315116
  • 项目类别:
    Operating Grants
  • 资助金额:
    $11.66万
  • 财政年份:
    2014
  • 负责人:
    Tsao Ming-Sound
  • 依托单位:
Study of SOX2-mediated oncogenesis in lung squamous cell carcinoma
  • 批准号:
    313974
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2014
  • 负责人:
    Tsao Ming-Sound
  • 依托单位:
Functional Genomics and in vitro Modeling of Human Pancreatic Carcinogenesis
  • 批准号:
    305446
  • 项目类别:
    Operating Grants
  • 资助金额:
    $54.95万
  • 财政年份:
    2014
  • 负责人:
    Tsao Ming-Sound
  • 依托单位:
海外基金